Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Effect of Early Surgery vs Endoscopy-First Approach on Pain in Patients With Chronic Pancreatitis: The ESCAPE Randomized Clinical Trial.

Issa Y, Kempeneers MA, Bruno MJ, Fockens P, Poley JW, Ahmed Ali U, Bollen TL, Busch OR, Dejong CH, van Duijvendijk P, van Dullemen HM, van Eijck CH, van Goor H, Hadithi M, Haveman JW, Keulemans Y, Nieuwenhuijs VB, Poen AC, Rauws EA, Tan AC, Thijs W, Timmer R, Witteman BJ, Besselink MG, van Hooft JE, van Santvoort HC, Dijkgraaf MG, Boermeester MA; Dutch Pancreatitis Study Group.

JAMA. 2020 Jan 21;323(3):237-247. doi: 10.1001/jama.2019.20967.

PMID:
31961419
2.

Riboflavin supplementation in patients with Crohn's disease (RISE-UP study).

von Martels JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, Sadaghian Sadabad M, Vich Vila A, Gacesa R, Gabriëls RY, Steinert RE, Jansen BH, Bulthuis MLC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, de Vos P, van Goor H, Faber KN, Harmsen HJM, Dijkstra G.

J Crohns Colitis. 2019 Dec 24. pii: jjz208. doi: 10.1093/ecco-jcc/jjz208. [Epub ahead of print]

PMID:
31873717
3.

A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease.

Bourgonje AR, von Martels JZH, Gabriëls RY, Blokzijl T, Buist-Homan M, Heegsma J, Jansen BH, van Dullemen HM, Festen EAM, Ter Steege RWF, Visschedijk MC, Weersma RK, de Vos P, Faber KN, Dijkstra G.

Front Med (Lausanne). 2019 Nov 5;6:251. doi: 10.3389/fmed.2019.00251. eCollection 2019.

4.

Reliability of clinical nodal status regarding response to neoadjuvant chemoradiotherapy compared with surgery alone and prognosis in esophageal cancer patients.

Dijksterhuis WPM, Hulshoff JB, van Dullemen HM, Kats-Ugurlu G, Burgerhof JGM, Korteweg T, Mul VEM, Hospers GAP, Plukker JTM.

Acta Oncol. 2019 Nov;58(11):1640-1647. doi: 10.1080/0284186X.2019.1648865. Epub 2019 Aug 9.

PMID:
31397195
5.

Correction to: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1.

Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vila AV, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK.

BMC Gastroenterol. 2019 Mar 27;19(1):44. doi: 10.1186/s12876-019-0938-8.

6.

The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1.

Imhann F, Van der Velde KJ, Barbieri R, Alberts R, Voskuil MD, Vich Vila A, Collij V, Spekhorst LM, Van der Sloot KWJ, Peters V, Van Dullemen HM, Visschedijk MC, Festen EAM, Swertz MA, Dijkstra G, Weersma RK.

BMC Gastroenterol. 2019 Jan 8;19(1):5. doi: 10.1186/s12876-018-0917-5. Erratum in: BMC Gastroenterol. 2019 Mar 27;19(1):44.

7.

Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.

Vich Vila A, Imhann F, Collij V, Jankipersadsing SA, Gurry T, Mujagic Z, Kurilshikov A, Bonder MJ, Jiang X, Tigchelaar EF, Dekens J, Peters V, Voskuil MD, Visschedijk MC, van Dullemen HM, Keszthelyi D, Swertz MA, Franke L, Alberts R, Festen EAM, Dijkstra G, Masclee AAM, Hofker MH, Xavier RJ, Alm EJ, Fu J, Wijmenga C, Jonkers DMAE, Zhernakova A, Weersma RK.

Sci Transl Med. 2018 Dec 19;10(472). pii: eaap8914. doi: 10.1126/scitranslmed.aap8914.

PMID:
30567928
8.

Impact of Endoscopic Ultrasonography on 18F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment.

Hulshoff JB, Mul VEM, de Boer HEM, Noordzij W, Korteweg T, van Dullemen HM, Nagengast WB, Oppedijk V, Pierie JPEN, Plukker JTM.

Ann Surg Oncol. 2017 Jul;24(7):1828-1834. doi: 10.1245/s10434-017-5835-1. Epub 2017 Mar 16.

9.

Prevalence and Progression of Pancreatic Cystic Precursor Lesions Differ Between Groups at High Risk of Developing Pancreatic Cancer.

Konings IC, Harinck F, Poley JW, Aalfs CM, van Rens A, Krak NC, Wagner A, Nio CY, Sijmons RH, van Dullemen HM, Vleggaar FP, Ausems MG, Fockens P, van Hooft JE, Bruno MJ; Dutch Research Group on Pancreatic Cancer Surveillance in High-Risk Individuals.

Pancreas. 2017 Jan;46(1):28-34.

PMID:
27846136
10.

Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.

Imhann F, Vich Vila A, Bonder MJ, Fu J, Gevers D, Visschedijk MC, Spekhorst LM, Alberts R, Franke L, van Dullemen HM, Ter Steege RWF, Huttenhower C, Dijkstra G, Xavier RJ, Festen EAM, Wijmenga C, Zhernakova A, Weersma RK.

Gut. 2018 Jan;67(1):108-119. doi: 10.1136/gutjnl-2016-312135. Epub 2016 Oct 8.

11.

Potential value of EUS in pancreatic surveillance of VHL patients.

van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Koopmans KP, Kema IP, Zonnenberg BA, Timmers HJ, de Herder WW, Sluiter WJ, de Vries EG, Links TP.

Eur J Endocrinol. 2016 May;174(5):611-20. doi: 10.1530/EJE-15-1012. Epub 2016 Feb 16.

PMID:
26884551
12.

Early biliary decompression versus conservative treatment in acute biliary pancreatitis (APEC trial): study protocol for a randomized controlled trial.

Schepers NJ, Bakker OJ, Besselink MG, Bollen TL, Dijkgraaf MG, van Eijck CH, Fockens P, van Geenen EJ, van Grinsven J, Hallensleben ND, Hansen BE, van Santvoort HC, Timmer R, Anten MP, Bolwerk CJ, van Delft F, van Dullemen HM, Erkelens GW, van Hooft JE, Laheij R, van der Hulst RW, Jansen JM, Kubben FJ, Kuiken SD, Perk LE, de Ridder RJ, Rijk MC, Römkens TE, Schoon EJ, Schwartz MP, Spanier BW, Tan AC, Thijs WJ, Venneman NG, Vleggaar FP, van de Vrie W, Witteman BJ, Gooszen HG, Bruno MJ; Dutch Pancreatitis Study Group.

Trials. 2016 Jan 5;17:5. doi: 10.1186/s13063-015-1132-0.

13.

[A woman with painful ulcera on her lower leg].

Schreuder RM, Horváth B, van Dullemen HM.

Ned Tijdschr Geneeskd. 2015;159:A8783. Dutch.

PMID:
26131750
14.

A multicentre comparative prospective blinded analysis of EUS and MRI for screening of pancreatic cancer in high-risk individuals.

Harinck F, Konings IC, Kluijt I, Poley JW, van Hooft JE, van Dullemen HM, Nio CY, Krak NC, Hermans JJ, Aalfs CM, Wagner A, Sijmons RH, Biermann K, van Eijck CH, Gouma DJ, Dijkgraaf MG, Fockens P, Bruno MJ; Dutch research group on pancreatic cancer surveillance in high-risk individuals.

Gut. 2016 Sep;65(9):1505-13. doi: 10.1136/gutjnl-2014-308008. Epub 2015 May 18.

PMID:
25986944
15.

EUS is superior for detection of pancreatic lesions compared with standard imaging in patients with multiple endocrine neoplasia type 1.

van Asselt SJ, Brouwers AH, van Dullemen HM, van der Jagt EJ, Bongaerts AH, Kema IP, Koopmans KP, Valk GD, Timmers HJ, de Herder WW, Feelders RA, Fockens P, Sluiter WJ, de Vries EG, Links TP.

Gastrointest Endosc. 2015 Jan;81(1):159-167.e2. doi: 10.1016/j.gie.2014.09.037.

PMID:
25527055
16.

Dutch Chronic Pancreatitis Registry (CARE): design and rationale of a nationwide prospective evaluation and follow-up.

Ahmed Ali U, Issa Y, van Goor H, van Eijck CH, Nieuwenhuijs VB, Keulemans Y, Fockens P, Busch OR, Drenth JP, Dejong CH, van Dullemen HM, van Hooft JE, Siersema PD, Spanier BW, Poley JW, Poen AC, Timmer R, Seerden T, Tan AC, Thijs WJ, Witteman BJ, Romkens TE, Roeterdink AJ, Gooszen HG, van Santvoort HC, Bruno MJ, Boermeester MA; Dutch Pancreatitis Study Group.

Pancreatology. 2015 Jan-Feb;15(1):46-52. doi: 10.1016/j.pan.2014.11.002. Epub 2014 Nov 29.

PMID:
25511908
17.

Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).

Dewint P, Hansen BE, Verhey E, Oldenburg B, Hommes DW, Pierik M, Ponsioen CI, van Dullemen HM, Russel M, van Bodegraven AA, van der Woude CJ.

Gut. 2014 Feb;63(2):292-9. doi: 10.1136/gutjnl-2013-304488. Epub 2013 Mar 23.

PMID:
23525574
18.

Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial.

Ahmed Ali U, Issa Y, Bruno MJ, van Goor H, van Santvoort H, Busch OR, Dejong CH, Nieuwenhuijs VB, van Eijck CH, van Dullemen HM, Fockens P, Siersema PD, Gouma DJ, van Hooft JE, Keulemans Y, Poley JW, Timmer R, Besselink MG, Vleggaar FP, Wilder-Smith OH, Gooszen HG, Dijkgraaf MG, Boermeester MA; Dutch Pancreatitis Study Group.

BMC Gastroenterol. 2013 Mar 18;13:49. doi: 10.1186/1471-230X-13-49.

19.

Pancreatic cyst development: insights from von Hippel-Lindau disease.

van Asselt SJ, de Vries EG, van Dullemen HM, Brouwers AH, Walenkamp AM, Giles RH, Links TP.

Cilia. 2013 Feb 5;2(1):3. doi: 10.1186/2046-2530-2-3.

20.

Tailored imaging of islet cell tumors of the pancreas amidst increasing options.

Fiebrich HB, van Asselt SJ, Brouwers AH, van Dullemen HM, Pijl ME, Elsinga PH, Links TP, de Vries EG.

Crit Rev Oncol Hematol. 2012 May;82(2):213-26. doi: 10.1016/j.critrevonc.2011.05.006. Epub 2011 Jun 25. Review.

PMID:
21704529
21.

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?

Schreurs LM, Janssens AC, Groen H, Fockens P, van Dullemen HM, van Berge Henegouwen MI, Sloof GW, Pruim J, van Lanschot JJ, Steyerberg EW, Plukker JT.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):1021-1028. Epub 2011 May 6.

22.

Endoscopic ultrasonography in suspected pancreatic malignancy and indecisive CT.

Meijer OL, Weersma RK, van der Jagt EJ, van Dullemen HM.

Neth J Med. 2010 Sep;68(9):360-4.

23.

Procedure-related, false-positive cytology results during EUS-guided FNA in patients with esophageal cancer.

van Hemel BM, Lamprou AA, Weersma R, Plukker JT, Suurmeijer AJ, van Dullemen HM.

Gastrointest Endosc. 2010 Jun;71(7):1130-3. doi: 10.1016/j.gie.2010.01.051.

PMID:
20598243
24.

Prognostic factors and patterns of recurrence in esophageal cancer assert arguments for extended two-field transthoracic esophagectomy.

Smit JK, Pultrum BB, van Dullemen HM, Van Dam GM, Groen H, Plukker JT.

Am J Surg. 2010 Oct;200(4):446-53. doi: 10.1016/j.amjsurg.2009.12.006. Epub 2010 Apr 20.

PMID:
20409512
25.

A critical appraisal of circumferential resection margins in esophageal carcinoma.

Pultrum BB, Honing J, Smit JK, van Dullemen HM, van Dam GM, Groen H, Hollema H, Plukker JT.

Ann Surg Oncol. 2010 Mar;17(3):812-20. doi: 10.1245/s10434-009-0827-4.

26.

Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study.

Pultrum BB, van der Jagt EJ, van Westreenen HL, van Dullemen HM, Kappert P, Groen H, Sietsma J, Oudkerk M, Plukker JT, van Dam GM.

Cancer Imaging. 2009 Apr 6;9:19-28. doi: 10.1102/1470-7330.2009.0004.

27.

Transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND-study).

van den Broek FJ, de Graaf EJ, Dijkgraaf MG, Reitsma JB, Haringsma J, Timmer R, Weusten BL, Gerhards MF, Consten EC, Schwartz MP, Boom MJ, Derksen EJ, Bijnen AB, Davids PH, Hoff C, van Dullemen HM, Heine GD, van der Linde K, Jansen JM, Mallant-Hent RC, Breumelhof R, Geldof H, Hardwick JC, Doornebosch PG, Depla AC, Ernst MF, van Munster IP, de Hingh IH, Schoon EJ, Bemelman WA, Fockens P, Dekker E.

BMC Surg. 2009 Mar 13;9:4. doi: 10.1186/1471-2482-9-4.

28.

Colonoscopy training for nurse endoscopists: a feasibility study.

Koornstra JJ, Corporaal S, Giezen-Beintema WM, de Vries SE, van Dullemen HM.

Gastrointest Endosc. 2009 Mar;69(3 Pt 2):688-95. doi: 10.1016/j.gie.2008.09.028.

PMID:
19251011
29.

A safe technique for removing a malpositioned covered biliary self-expandable metal stent.

Koornstra JJ, van Dullemen HM, Weersma RK.

Endoscopy. 2008 Sep;40 Suppl 2:E165. doi: 10.1055/s-2007-995791. No abstract available.

PMID:
18668454
30.

Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.

Weersma RK, Zhou L, Nolte IM, van der Steege G, van Dullemen HM, Oosterom E, Bok L, Peppelenbosch MP, Faber KN, Kleibeuker JH, Dijkstra G.

Inflamm Bowel Dis. 2008 Dec;14(12):1615-22. doi: 10.1002/ibd.20610.

PMID:
18668679
31.

[Diagnostics and treatment of cholangiocarcinoma].

Mantel HT, Verdonk RC, van Dullemen HM, Gietema JA, Slooff MJ, Porte RJ.

Ned Tijdschr Geneeskd. 2008 May 3;152(18):1037-41. Review. Dutch.

PMID:
18547024
32.

Importance of fluorodeoxyglucose-positron emission tomography (FDG-PET) and endoscopic ultrasonography parameters in predicting survival following surgery for esophageal cancer.

Omloo JM, Sloof GW, Boellaard R, Hoekstra OS, Jager PL, van Dullemen HM, Fockens P, Plukker JT, van Lanschot JJ.

Endoscopy. 2008 Jun;40(6):464-71. doi: 10.1055/s-2008-1077302.

PMID:
18543134
33.

Impact of splenectomy on surgical outcome in patients with cancer of the distal esophagus and gastro-esophageal junction.

Pultrum BB, van Bastelaar J, Schreurs LM, van Dullemen HM, Groen H, Nijsten MW, van Dam GM, Plukker JT.

Dis Esophagus. 2008;21(4):334-9. doi: 10.1111/j.1442-2050.2007.00762.x.

PMID:
18477256
34.

Are pancreatic autoantibodies associated with azathioprine-induced pancreatitis in Crohn's disease?

Weersma RK, Batstra MR, Kleibeuker JH, van Dullemen HM.

JOP. 2008 May 8;9(3):283-9.

35.

Review article: Inflammatory bowel disease and genetics.

Weersma RK, van Dullemen HM, van der Steege G, Nolte IM, Kleibeuker JH, Dijkstra G.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:57-65. doi: 10.1111/j.1365-2036.2007.03476.x. Review.

36.

Mediastinal emphysema complicating diabetic ketoacidosis: plea for conservative diagnostic approach.

Pauw RG, van der Werf TS, van Dullemen HM, Dullaart RP.

Neth J Med. 2007 Nov;65(10):368-71. Review.

37.

ATG16L1 and IL23R are associated with inflammatory bowel diseases but not with celiac disease in the Netherlands.

Weersma RK, Zhernakova A, Nolte IM, Lefebvre C, Rioux JD, Mulder F, van Dullemen HM, Kleibeuker JH, Wijmenga C, Dijkstra G.

Am J Gastroenterol. 2008 Mar;103(3):621-7. Epub 2007 Nov 28.

PMID:
18047540
38.

Limited additional value of positron emission tomography in staging oesophageal cancer.

van Westreenen HL, Westerterp M, Sloof GW, Groen H, Bossuyt PM, Jager PL, Comans EF, van Dullemen HM, Fockens P, Stoker J, van der Jagt EJ, van Lanschot JJ, Plukker JT.

Br J Surg. 2007 Dec;94(12):1515-20.

PMID:
17902092
39.

Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.

Weersma RK, Oostenbrug LE, Nolte IM, Van Der Steege G, Oosterom E, Van Dullemen HM, Kleibeuker JH, Dijkstra G.

Scand J Gastroenterol. 2007 Jul;42(7):827-33.

PMID:
17558906
40.

Absence of association between the multidrug resistance (MDR1) gene and inflammatory bowel disease.

Oostenbrug LE, Dijkstra G, Nolte IM, van Dullemen HM, Oosterom E, Faber KN, de Jong DJ, van der Linde K, te Meerman GJ, van der Steege G, Kleibeuker JH, Jansen PL.

Scand J Gastroenterol. 2006 Oct;41(10):1174-82.

PMID:
16990202
41.

CARD15 in inflammatory bowel disease and Crohn's disease phenotypes: an association study and pooled analysis.

Oostenbrug LE, Nolte IM, Oosterom E, van der Steege G, te Meerman GJ, van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH.

Dig Liver Dis. 2006 Nov;38(11):834-45. Epub 2006 Aug 21.

PMID:
16920047
42.

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

van Dullemen HM, Kleibeuker JH.

Scand J Gastroenterol Suppl. 2006;(243):55-8. Review.

PMID:
16894670
43.

Outcome of palliative care regimens in patients with advanced oesophageal cancer detected during explorative surgery.

Pultrum BB, van Westreenen HL, Mulder NH, van Dullemen HM, Plukker JT.

Anticancer Res. 2006 May-Jun;26(3B):2289-93.

44.

Chemoprevention for colon cancer: new opportunities, fact or fiction?

Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.

Scand J Gastroenterol Suppl. 2006;(243):158-64. Review.

PMID:
16782636
45.

Intestinal transplantation in The Netherlands: first experience and future perspectives.

Dijkstra G, Rings EH, Bijleveld CM, Van Dullemen HM, Hofker HS, Porte RJ, Ploeg RJ.

Scand J Gastroenterol Suppl. 2006;(243):39-45. Review.

PMID:
16782621
46.

Clinical outcome of Crohn's disease according to the Vienna classification: disease location is a useful predictor of disease course.

Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL, Kleibeuker JH.

Eur J Gastroenterol Hepatol. 2006 Mar;18(3):255-61.

PMID:
16462538
47.

[Treatment of servere ulcerative colitis].

Weersma RK, van Dullemen HM, Kleibeuker JH, Ploeg RJ, Dijkstra G.

Ned Tijdschr Geneeskd. 2006 Jan 7;150(1):12-7. Review. Dutch.

PMID:
16440618
48.

Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells.

van der Waaij LA, Harmsen HJ, Madjipour M, Kroese FG, Zwiers M, van Dullemen HM, de Boer NK, Welling GW, Jansen PL.

Inflamm Bowel Dis. 2005 Oct;11(10):865-71.

PMID:
16189415
49.

Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis.

van der Waaij LA, van Dullemen HM, Porte RJ.

Gastrointest Endosc. 2005 Sep;62(3):383-9. Review.

PMID:
16111956
50.

Synchronous primary neoplasms detected on 18F-FDG PET in staging of patients with esophageal cancer.

van Westreenen HL, Westerterp M, Jager PL, van Dullemen HM, Sloof GW, Comans EF, van Lanschot JJ, Wiggers T, Plukker JT.

J Nucl Med. 2005 Aug;46(8):1321-5.

Supplemental Content

Loading ...
Support Center